Thalidezine triggers Cathepsin B-mediated cell death in T-cell lymphoma by disrupting lysosomal function.

T-cell lymphoma (TCL) is an aggressive malignancy defined by poor prognosis and therapeutic resistance, demanding innovative strategies. Targeting the lysosome to induce cell death has emerged as a powerful anti-cancer strategy, however its potential…

Preview only. Read the full abstract at the source